Clinical trials
Platelets clinical trials
Below are recruiting platelets clinical trials, each written for real people, not researchers. We’re tracking 234 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06757764RecruitingPhase 4
Stroke from artery narrowing: testing combination of anti-platelet drugs
This trial tests whether a combination of two or three anti-platelet medicines (like aspirin, clopidogrel, or cilostazol) is safe and works better than one alone for people who had a stroke from a narrowed artery. The goal is to prevent another stroke.
Seoul, Songpa-guAges 20 years+ - NCT06747000Recruiting
Study of fats in blood and platelets
This study looks at how fats (lipids) in your blood affect blood cells called platelets, which help with clotting. It includes both healthy people and those with high cholesterol or other fat issues.
East Providence, Rhode IslandAges 18–69 - NCT06717295Recruiting
Blood test to find cancer early and track treatment
This study uses a blood test that looks at your platelets and immune cells to find common cancers early, and for certain cancers, to monitor how well treatment is working.
RosarioAges 40–75 - NCT05004233Recruiting
Antiplatelet treatment imaging test for stroke patients
This study uses special microscope imaging (transmission electron microscopy) to look at tiny changes in platelets before and after starting an antiplatelet medicine. It’s testing whether platelets show clear structural signs around the start of treatment for a specific type of stroke.
Saint-EtienneAges 18 years+ - NCT06657651Enrolling by invitation
Immediate Implant with Different Membranes for Lower Back Teeth
This study tests placing a dental implant and a special membrane right after removing a damaged lower back tooth. It looks at how well different types of membranes help the bone heal around the implant.
Al MansurahAges 18–60 - NCT06535568Recruiting
Comparing one vs two blood thinners after heart artery balloon treatment
This trial tests whether taking just one blood thinner (clopidogrel) is as safe and effective as taking two (clopidogrel plus aspirin) for older adults or people at high bleeding risk who have had a drug-coated balloon procedure to open blocked heart arteries.
Milan, MIAges Any age - NCT06536062Recruiting
Cord blood and platelet plasma for dry macular degeneration
This trial tests if a treatment made from umbilical cord blood and platelet-rich plasma can help people with dry age-related macular degeneration. The treatment is given as an injection into the eye, and the goal is to see if it slows vision loss or improves sight.
Rome, RomeAges 65 years+ - NCT06432387Recruiting
Blood clotting changes during complex aneurysm repair
This study looks at how blood clotting factors change during a complex aneurysm repair. It may help doctors better understand and manage bleeding risks.
Larissa, ThessalyAges 18 years+ - NCT06425614Recruiting
Blood Cell Recycling During Heart Surgery Trial
This trial tests whether giving back a patient's own platelets and red blood cells during heart surgery can reduce bleeding and the need for donor blood transfusions. It is for people having certain types of high-risk heart surgery with a heart-lung machine.
Bordeaux, FranceAges 18 years+ - NCT05732701Recruiting
Personalized blood thinner plan after stent placement
This trial tests an algorithm (computer-guided plan) to choose the best “dual antiplatelet therapy” (two blood-thinning medicines) after a coronary stent. It aims to improve outcomes after the procedure while reducing avoidable problems from the medicines.
Banja LukaAges 18 years+ - NCT05706896Recruiting
Cord blood plasma injections for dry macular degeneration
This trial tests whether injections made from umbilical cord blood “platelet-rich plasma” can improve vision in people with dry age-related macular degeneration (AMD) in both eyes. It targets older adults with specific vision levels and no major other eye or medical problems that could affect the results.
RomeAges 65 years+ - NCT06163573RecruitingPhase 2
Engineered cartilage for kneecap arthritis
This trial tests a new way to treat arthritis in the kneecap area using specially grown cartilage. If you have kneecap pain and haven't been helped by other treatments, this might be an option to discuss with your doctor.
ZagrebAges 18–65 - NCT02844764RecruitingPhase 2
Cell therapy test for hip osteoarthritis pain and swelling
This trial tests an “autologous” regenerative cell treatment, meaning cells taken from you, to reduce hip osteoarthritis pain and inflammation. It checks safety first and looks for improvements in how you feel and move.
Grove City, PennsylvaniaAges 18–90 - NCT02844738RecruitingPhase 2
Cell therapy for shoulder osteoarthritis pain and inflammation
This trial tests a treatment using your own (autologous) regenerative cells to reduce pain and inflammation from shoulder osteoarthritis. It may help people with long-lasting shoulder pain, but you must meet several health and medication timing requirements.
Grove City, PennsylvaniaAges 18–90 - NCT00230165Recruiting
Genetics and blood testing for inherited bleeding disorders
This study looks at genes and blood function in people with inherited (passed-down) problems with platelets, white blood cells, or blood clotting. It may help improve understanding of the cause of these conditions and how they work in the body.
New York, New YorkAges Any age - NCT06090669RecruitingPhase 1
Trial of imatinib for people with RUNX1 deficiency
This trial tests if imatinib can help people with a genetic condition called RUNX1 deficiency, which causes bleeding problems. It aims to increase the activity of the RUNX1 gene to improve blood clotting.
Bethesda, MarylandAges 18–120 - NCT03378934RecruitingPhase 4
Berberine after stent placement to reduce blood-platelet effects
This trial studies whether berberine changes how strongly your platelets “stick together” after a coronary stent. It may help reduce risk related to clotting while you continue standard heart medicines (aspirin and clopidogrel).
Beijing, Beijing MunicipalityAges 18–70 - NCT05885932Recruiting
Stent treatment versus medicines for blocked neck artery
This study compares a drug-coated stent placed in a neck (vertebral) artery versus best medical treatment with medicines and risk-factor control. It aims to reduce problems caused by a badly narrowed artery after recent stroke-like symptoms.
BeijingAges 18 years+ - NCT05907629Recruiting
MRI study comparing blood thinners after a certain stroke
This trial looks at MRI scans to compare two types of blood-thinning medicines (one that affects blood-clotting and one that affects platelets) after a recent stroke caused by severe narrowing in certain brain arteries. It may help doctors understand which treatment works best while checking how the blood vessels and brain tissue look on MRI.
Birmingham, AlabamaAges 18 years+ - NCT05713734Recruiting
Study of unexplained bleeding blood tests in adults
This Swiss study looks at people with unexplained bleeding by using a standardized bleeding score and taking a blood sample. It may help researchers better understand possible bleeding causes even when the reason isn’t clear yet.
BellinzonaAges 16–65 - NCT05711485Recruiting
Platelet-directed whole blood transfusion for malaria in young children
This study is testing a new way to use whole blood transfusions to treat severe malaria in young children. It might help children with very low platelet counts and low hemoglobin recover better.
Baltimore, MarylandAges 1 month–4.9 years - NCT05628974Recruiting
Healthy adults can donate blood for platelet testing
This study looks at how platelets work and checks blood markers using donations from healthy volunteers. It may help researchers design future platelet-related treatments and better tests.
Cleveland, OhioAges 18–65 - NCT05591326Enrolling by invitation
Injectable platelet-rich fibrin to close gum recession
This trial tests whether an injectable healing material called platelet-rich fibrin can help cover exposed tooth root in front teeth with gum recession. If it works, it may reduce tooth sensitivity and improve appearance for people with suitable, healthy teeth and gums.
KütahyaAges 18–65 - NCT05518305Recruiting
Predicting recurrent stroke risk in people with artery narrowing
This study looks at blood markers and brain/artery scan results to predict who with intracranial artery narrowing is more likely to have another stroke. It may help doctors spot higher-risk people earlier and better target prevention.
Los Angeles, CaliforniaAges 30 years+
Hear when a new Platelets trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for platelets?
- Yes. Clin2 currently lists 234 recruiting platelets studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a platelets trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a platelets trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.